Announcing results, gravitating just below $0.02 per share - this is Genta Incorporated Inc(OTC:GNTA, GNTA message board) this week. A free fall most of the time, with rare exceptions when a period of stability in the stock price would put the stock in this sharp decline that the company is still unable to escape from. 
So, news at hand. Last week, Genta presented the updated results on Phase 2 Trial of Tesetaxel. Yet, it was not optimistic enough as there was no major development on the market during the last session of the week. A 9% increase in a stock price for Friday and 21 million shares changing hands. In fact, what happened last Friday is more or less the same as during Thursday's session. An announcement about the same product, virtually the same number of traded shares, no major changes in the share price. All in all, Genta shareholders are still waiting for the one announcement that would cause this stock to skyrocket again.
In the meantime, quarterly statements come out, which also point in the direction that it is high time for a reverse trend on the stock market. The latest 10-Q with an end date March, 31 this year includes figures like:
- $8.8 million in cash;
- $9.5 million in total current assets;
- $5.3 million in total current liabilities;
- $513k in net loss;
- $1.1 billion in accumulated deficit;
So, Genta has the money needed to continue pursuing its goals. It also has the billion of deficit that should be taken into account. There are possibilities for profits out of the regular press releases of the company that pick up the stock price, even for a short while. Yet, a stock that traded above $2 roughly 6 months ago now trades below 2 cents. Not a sign that this company is doomed. Yet, certainly a sign that caution should be applied when making an investment decision.
Comments (0)